These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. An attempt to identify the nature of immunoglobulin-complement deposits in the skin in lupus erythematosus. van Joost T Br J Dermatol; 1973 Jul; 89(1):15-20. PubMed ID: 4596153 [No Abstract] [Full Text] [Related]
51. Exchange autografts of skin in lupus erythematosus. Cormane RH; Bruinsma W Ann Clin Res; 1970 Mar; 2(1):22-7. PubMed ID: 4393043 [No Abstract] [Full Text] [Related]
52. [Immunological studies on DNA antibodies in lupus erythematosus (SLE, cDLE), with particular reference to photo-oxidized DNA (poDNA) antibody]. Okuda M Arerugi; 1970 Apr; 19(4):260-6. PubMed ID: 5448917 [No Abstract] [Full Text] [Related]
53. [Immunofluorescence reaction in the diagnosis of lupus erythematosus]. Butov IuS Vestn Dermatol Venerol; 1982 Jul; (7):30-6. PubMed ID: 6753405 [No Abstract] [Full Text] [Related]
55. [Data on the study of the clinical aspects, diagnosis, therapy and prevention of allergic reactions in dermatology]. Sidaravichius BIu; Gaĭliavichius PP; Shabrinskas VI; Ragaĭshis SL Vestn Dermatol Venerol; 1969 Jul; 43(7):3-7. PubMed ID: 4247561 [No Abstract] [Full Text] [Related]
56. [Serum levels of immunoglobulins in systemic lupus erythematosus]. Rovenskỳ J; Cebecauer L; Zitnan D Vnitr Lek; 1971 May; 17(5):457-62. PubMed ID: 5170721 [No Abstract] [Full Text] [Related]
57. 1982 revised criteria for classification of systemic lupus erythematosus--ten years later. Font J; Cervera R Lupus; 1993 Oct; 2(5):339-41; discussion 343. PubMed ID: 8305930 [No Abstract] [Full Text] [Related]
59. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus]. Bardare M; Menghi P Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914 [No Abstract] [Full Text] [Related]